Muscle glycogen content in type 2 diabetes mellitus. (Q51529037)

6 April 2018

title

Muscle glycogen content in type 2 diabetes mellitus. (English)

1 reference

6 April 2018

glycogen metabolic process

main subject

type 2 diabetes

0 references

1 reference

Jing He

1

1 reference

6 April 2018

David E Kelley

series ordinal

2

1 reference

6 April 2018

publication date

13 July 2004

1 reference

6 April 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

6 April 2018

volume

287

1 reference

6 April 2018

issue

5

1 reference

6 April 2018

page(s)

E1002-7

1 reference

6 April 2018

Mechanisms of fatty acid-induced inhibition of glucose uptake

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Effect of muscle glycogen depletion on in vivo insulin action in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Prevention of glycogen supercompensation prolongs the increase in muscle GLUT4 after exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Role of muscle in triglyceride metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Intracellular defects in glucose metabolism in obese patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Overnutrition induced decrease in insulin action for glucose storage: in vivo and in vitro in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Minireview: nutrient sensing and the regulation of insulin action and energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Skeletal muscle triglyceride levels are inversely related to insulin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

The increase in intramyocellular lipid content is a very early response to training

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Mitochondrial disorders: clinical and genetic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00015.2004

10.1152/AJPENDO.00015.2004

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

15251866

1 reference

6 April 2018